Related references
Note: Only part of the references are listed.Percutaneous image-guided biopsy of prostate cancer metastases yields samples suitable for genomics and personalised oncology
Matthew K. H. Hong et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
A Panel of Three Markers Hyper- and Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence
Sheng-Fang Su et al.
CLINICAL CANCER RESEARCH (2014)
The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: A multi-institutional study
Nobuyuki Tanaka et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Combination of Molecular Alterations and Smoking Intensity Predicts Bladder Cancer Outcome A Report From the Los Angeles Cancer Surveillance Program
Anirban P. Mitra et al.
CANCER (2013)
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
Daehwan Kim et al.
GENOME BIOLOGY (2013)
Batch correction of microarray data substantially improves the identification of genes differentially expressed in Rheumatoid Arthritis and Osteoarthritis
Peter Kupfer et al.
BMC MEDICAL GENOMICS (2012)
An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer
S. Miah et al.
BRITISH JOURNAL OF CANCER (2012)
Hedgehog Signaling Regulates Bladder Cancer Growth and Tumorigenicity
Dennis Liang Fei et al.
CANCER RESEARCH (2012)
Expression of microRNAs in the Urine of Patients With Bladder Cancer
Gang Wang et al.
CLINICAL GENITOURINARY CANCER (2012)
MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1
Yuan Li et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics
Marc Lohse et al.
NUCLEIC ACIDS RESEARCH (2012)
Oncogenic miRNA-182-5p Targets Smad4 and RECK in Human Bladder Cancer
Hiroshi Hirata et al.
PLOS ONE (2012)
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
James W. F. Catto et al.
EUROPEAN UROLOGY (2011)
DNA Damage, Somatic Aneuploidy, and Malignant Sarcoma Susceptibility in Muscular Dystrophies
Wolfgang M. Schmidt et al.
PLOS GENETICS (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
The role of the miR-200 family in epithelial-mesenchymal transition
Perry S. Mongroo et al.
CANCER BIOLOGY & THERAPY (2010)
Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer
Pang-Kuo Lo et al.
CANCER RESEARCH (2010)
Prediction of Stage, Grade, and Survival in Bladder Cancer Using Genome-wide Expression Data: A Validation Study
Martin Lauss et al.
CLINICAL CANCER RESEARCH (2010)
Expression profiling for bladder cancer: strategies to uncover prognostic factors
Georg Bartsch et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
Ju-Seog Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer
Merle Hanke et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
MicroRNAs in Cancer
Ramiro Garzon et al.
ANNUAL REVIEW OF MEDICINE (2009)
miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
Liana Adam et al.
CLINICAL CANCER RESEARCH (2009)
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
Ben Langmead et al.
GENOME BIOLOGY (2009)
The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival
Nigel P. S. Crawford et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike Burk et al.
EMBO REPORTS (2008)
The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation
J. Veeck et al.
ONCOGENE (2008)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Clinical model of lifetime cost of treating bladder cancer and associated complications
Elenir B. C. Avritscher et al.
UROLOGY (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays
M Sanchez-Carbayo et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study
DI Daniltchenko et al.
JOURNAL OF UROLOGY (2005)
Combinatorial microRNA target predictions
A Krek et al.
NATURE GENETICS (2005)
The economic consequences of prostate and bladder cancer in the UK
VK Sangar et al.
BJU INTERNATIONAL (2005)
Gene expression in the urinary bladder:: A common carcinoma in situ gene expression signature exists disregarding histopathological classification
L Dyrskjot et al.
CANCER RESEARCH (2004)
Adherence to surveillance among patients with superficial bladder cancer
D Schrag et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice
MH Khadra et al.
JOURNAL OF UROLOGY (2000)
Share Paper
